[Form 4] EKSO BIONICS HOLDINGS, INC. Insider Trading Activity

Ekso Bionics Holdings, Inc. major shareholder Daniel Asher reported a series of indirect open-market purchases of common stock through DBA Trading, LLC between February 6 and February 13, 2026, at prices around the high-$8 to mid-$9 range per share.

Rhea-AI Filing Summary

Ekso Bionics Holdings, Inc. major shareholder Daniel Asher reported a series of indirect open-market purchases of common stock through DBA Trading, LLC between February 6 and February 13, 2026, at prices around the high-$8 to mid-$9 range per share.

Following these trades, DBA Trading, LLC held 258,792 shares of Ekso Bionics common stock indirectly for Asher, while he also reported 165,000 shares of common stock held directly. In addition, a trust for which Asher is grantor held 2,926 shares of convertible preferred stock, convertible into 355,960 shares of common stock, all reported as indirect beneficial ownership.

Insider Trade Summary

Net Buyer: 102,029 shares

Net Buy 10 txns

Insider ASHER DANIEL

Role 10% Owner

Bought 102,029 shs ($970K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	11,092	$9.1429	$101K
Purchase	Common Stock	16,100	$8.9611	$144K
Purchase	Common Stock	8,908	$9.1844	$82K
Purchase	Common Stock	30,124	$9.688	$292K
Purchase	Common Stock	20,611	$9.6924	$200K
Purchase	Common Stock	10,200	$9.924	$101K
Purchase	Common Stock	4,800	$9.9625	$48K
Purchase	Common Stock	194	$9.8552	$2K
holding	Convertible Preferred Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 258,792 shares (Indirect, by DBA Trading, LLC); Convertible Preferred Stock — 355,960 contracts (Indirect, By Daniel Asher Descendants Trust); Common Stock — 165,000 shares (Direct)

Footnotes (3)

1. F1. Daniel Asher is the beneficial owner of DBA Trading, LLC and deemed to control share voting and dispositive power over the shares held by them.
2. F2. Daniel Asher is the grantor of Daniel Asher Descendants Trust and deemed to control share voting and dispositive power over the shares held by them.
3. F3. None

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 03:42 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ASHER DANIEL

(Last) (First) (Middle)

1011 LAKE ST

SUITE 311

(Street)

OAK PARK IL 60301

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EKSO BIONICS HOLDINGS, INC. [ EKSO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/06/2026		P		194	A	$9.8552	156,957	I	by DBA Trading, LLC(1)
Common Stock	02/09/2026		P		4,800	A	$9.9625	161,757	I	by DBA Trading, LLC(1)
Common Stock	02/10/2026		P		10,200	A	$9.924	171,957	I	by DBA Trading, LLC(1)
Common Stock	02/11/2026		P		20,611	A	$9.6924	192,568	I	by DBA Trading, LLC(1)
Common Stock	02/12/2026		P		8,908	A	$9.1844	201,476	I	by DBA Trading, LLC(1)
Common Stock	02/12/2026		P		30,124	A	$9.688	231,600	I	by DBA Trading, LLC(1)
Common Stock	02/13/2026		P		11,092	A	$9.1429	242,692	I	by DBA Trading, LLC(1)
Common Stock	02/13/2026		P		16,100	A	$8.9611	258,792	I	by DBA Trading, LLC(1)
Common Stock								165,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Convertible Preferred Stock	$8.22							01/22/2026	(3)	Common Stock	355,960		2,926	I	By Daniel Asher Descendants Trust(2)

Explanation of Responses:

1. Daniel Asher is the beneficial owner of DBA Trading, LLC and deemed to control share voting and dispositive power over the shares held by them.

2. Daniel Asher is the grantor of Daniel Asher Descendants Trust and deemed to control share voting and dispositive power over the shares held by them.

3. None

	Daniel Asher	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.